We are continuously innovating, combining scientific rigor with an open-minded approach to deliver the next big thing. We are Exact Sciences, and we’re changing lives together through earlier detection and smarter answers. Our mission at Exact Sciences is to eradicate cancer and the suffering it causes — through tests that help prevent it, detection that finds it earlier, and guidance for its successful treatment. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, we help people face the most challenging decisions with confidence. Exact Sciences Laboratories are dedicated to delivering the most accurate test results to support informed decision making.
Temecula, United States
Founded in 2000
501-1000 Employees
Medium-Sized
Working industry
Biotechnology
Type of company
Educational institution
Ownership structure
Public Company
Locations
1 Headquarter
Number of products
14 Products
Specialised areas
Liquid biopsy, Pharmaceutical, Molecular diagnostics test for patients with cancer, Genetics, Genomic-based Clinical Laboratory Tests, Biotechnology, biotechnology, Health Care
Genomic Health offers a wide range of products and services
Product
The Pipeline | Exact Sciences
Go to product >
Product
Tests Oncotype DX | Exact Sciences
Go to product >
Product
Oncotype DX Tests | Exact Sciences
Go to product >
Product
オンコタイプDX検査 | Exact Sciences
Go to product >
Product
Die Pipeline | Exact Sciences
Go to product >
Product
Unsere Produkte | Exact Sciences
Go to product >
Product
製品 | Exact Sciences
Go to product >
Product
Our Products | Exact Sciences
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Genomic Health operates in 1 country around the world
Get an overview of the locations of Genomic Health
Location
Country
State
City
Headquarter
United States
California
Temecula
Some frequent questions that have been asked about Genomic Health
Where is Genomic Health located?
The company headquarter of Genomic Health is located in Temecula, California, United States. It's worth noting, that the company may have more locations
How many employees does Genomic Health approximately have?
As of the latest available information Genomic Health has around 501-1000 employees worldwide.
When was Genomic Health founded?
Genomic Health was founded in 2000
In which industries does Genomic Health mainly work?
The company Genomic Health has it's main focus in the industries of Biotechnology
What is the current company status of Genomic Health?
Based on the founding year and the amount of employees the company Genomic Health seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Genomic Health
Exactis Innovation
Montreal, Canada
11-50 Employees
2014
Exactis is committed to conducting its activities with the highest ethical and professional standards to ensure respectful treatment of patients and all stakeholders, this includes respecting the rights and privacy of patients, ethical standards, and regulatory requirements. Exactis Innovation (Exactis) is a Canadian not-for-profit focused on improving cancer survivorship by empowering the healthcare ecosystem to make more timely data-driven decisions through real-world data. Together, we are working towards better patient outcomes, longer lives, and a more efficient healthcare system. Our REB-approved Databank and clinical network make us a trusted Canadian partner for oncology real-world evidence (RWE) studies. We believe everyone has a role to play in fighting cancer.This is ours.
Universal Diagnostics
Seville, Spain
11-50 Employees
2012
We are driven forward by a vision of a future where cancer is curable. We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are applying our multi-omics, computational biology and machine learning approach to capture cancer’s signal for high-burden gastrointestinal cancers. Starting with colorectal cancer, we are building a multi-cancer platform that can identify the unique DNA regions associated with different types of cancers. Cancer’s early detection has become one of the greatest challenges of modern medicine, so we decided to team up with the best. Our company was founded on Silicon Valley’s ideals of technology and development (Singularity University), and we developed a network of world-class R&D partners including Quest Diagnostics and Hologic (Diagenode). Our Scientific Advisory Board includes leading oncologists, gastroenterologists and business experts from the US and Europe. We have built a network of >100 hospitals in the U.S.
RGCC
Switzerland
51-100 Employees
2004
We are experts in developing and providing personalised cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances. We encourage imaginative thinking to explore, question and reinvent, creating products, systems and technologies to challenge expectations. Working in the field of advanced medical genetics, our team of scientists and medical experts have developed a range of reliable tests so patients and clinicians can make informed decisions about healthcare. This is why we’re focused on creating modern and innovative products that will have a positive impact on day-to-day living.
Sysmex Inostics
Hamburg, Germany
51-100 Employees
2008
We aren't just your testing lab — we are here to support throughout your whole research to CDx journey. That discovery ignited our mission to leverage liquid insights in the body to transform research on a more personal, individual level. Located on the Johns Hopkins Medical Campus, we have played a leading role in the fight against cancers since our inception in 2008 and as a CLIA lab for the last 10 years. We believe each of us has a unique story to tell, so we test to track every molecule, changing outcomes for the better.
Ashion Analytics
Phoenix, United States
11-50 Employees
2014
At any stage of care, we provide actionable results tailored to each patient. No matter where your patient is with their cancer, Precision Oncology provides earlier detection and smarter answers. By delivering precise information about what’s in an individual’s tumor profile, it helps you show your patient what is and put an end to the “what ifs.”. The Oncotype DX® tests deliver clinically relevant genomic intelligence specific to the individual biology of a patient’s tumor—equipping physicians with the Exact insights they need. The OncoExTra™ test delivers rapid and comprehensive tumor profiling that aids therapy selection for patients with advanced or metastatic cancer—utilizing a complete biological picture to match their needs. That’s why we offer the Genomic Access Program (GAP) to help patients navigate the insurance and billing process.
Advanced Clinical Solution Laboratories
Branchburg Township, United States
1-10 Employees
2019
As a premiere molecular health laboratory, we harness cutting-edge technologies and expertise to deliver precise and actionable insights. Our team of scientists and healthcare professionals strives to provide accurate diagnoses and personalized treatment options, empowering individuals to make informed decisions about their health. At Advanced Clinical Solutions, we’re not just service providers – we’re your partners in care.